PharMetrics

Watertown, United States Founded: 1998 • Age: 28 yrs Acquired By IMS Health
Patient-level healthcare data solutions are provided to pharmaceutical sectors.

About PharMetrics

PharMetrics is a Technology company based in Watertown (United States) founded in 1998, and was acquired by IMS Health in June 2005. It operates as a patient-level healthcare data solutions are provided to pharmaceutical sectors. PharMetrics has raised $26 million across 3 funding rounds from investors including IQVIA, IMS Health and 3i Group. The company was acqui-hired. Its focus areas include Enterprise Applications, Data as a Service, Industries and Healthcare Data. Its competitors include Definitive Healthcare, ESO, Molecular Connections, Collaborative Drug Discovery and Borderless Access and 1 more; 3 of its 6 listed competitors have raised funding.

Company details

PharMetrics develops healthcare market insight solutions for the pharmaceutical, biotech, medical device, and managed care sectors of the healthcare market. The companys products include Market Profiler that provides a view of a therapeutic market, including market potential, patient demographics showing differences between treated and untreated populations, market segmentation, and an understanding of physician treatment behaviors. It also provides Treatment Profiler, which provides a longitudinal view of actual treatment patterns and allows marketers to understand how and where a particular product fits into the continuum of patient care; and Brand Profiler that provides a brand-specific view of the market, including detailed analysis of the sourceslosses of brand business for a competitive set of brands, and a detailed understanding of where a brand is winning and losing. In addition, the company offers custom analytics and database agreements. The company was founded in 1998 and is headquartered in Watertown, Massachusetts. As of July 1, 2005, PharMetrics, Inc. operates as a subsidiary of IMS Health Holdings, Inc.

Operational Areas
Key Metrics
  • Total Equity Funding
    $26M (USD)

    in 3 rounds

  • Latest Funding Round
    $8M (USD), Series D

    Nov 2004

  • Investors
    IQVIA

    & 4 more

  • Acquired by
    IMS Health

    (Jun 2005)

Funding Insights of PharMetrics

PharMetrics has successfully raised a total of $26M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $8 million completed in November 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $26M
  • Total Rounds 3
  • Last Round Series D β€” $8M
  • First Round $11M

    (May 2001)

  • Investors Count 3

All 3 funding rounds of PharMetrics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2004$8MSeries D–North Bridge Venture Partners, 3i Group
–
Sep 2002$7MSeries C––
May 2001$11MSeries B––
Valuation history

5 investors in total: 5 institutional.

Investors in PharMetrics

PharMetrics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include IQVIA, IMS Health and 3i Group.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
US focused seed to growth stage VC firm
–northbridge.comNeedham, United States
Private equity firm focused on mid-market businesses
19453i.comLondon, United Kingdom
-
–mediphaseventure.com-
Clinical research and commercialization solutions are provided for healthcare.
1982iqvia.comDurham, United States
SaaS and AI-based market intelligence is provided for healthcare companies.
1954imshealth.comDanbury, United States
Premium access

Investor details for PharMetrics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of PharMetrics

4 dated milestones of PharMetrics across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded PharMetrics is founded.
  2. Funding First funding round of $11.0M.
  3. Funding Latest funding round, Series D, of $8.0M.
  4. Exit Acquired by IMS Health.

Competitors of PharMetrics

PharMetrics has 6 listed competitors in our database, 3 of them funded. They include Definitive Healthcare, ESO, Molecular Connections, Collaborative Drug Discovery and Borderless Access, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
definitivehc.com2008Natick, United States$4.31M575
Offers market intelligence and data analytics for healthcare providers and physicians
eso.com2004Austin, United States$50.4M–
EHR platform for emergency services is provided.
molecularconnections.com2002Bengaluru, India–1,404
Databases and analytics for drug discovery are provided.
collaborativedrug.com2004Burlingame, United States–31
Biological and chemical data are managed securely in a database.
borderlessaccess.com2008Bengaluru, India$253,247356
Analytics-driven sampling suite for healthcare market research is offered.
biocentury.com1992Redwood, United States–171
Information, analysis, and data for biotech and pharma are provided.
Premium access

Detailed competitors of PharMetrics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Data as a Service

10 companies that operate in the same segment as PharMetrics (Data as a Service), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Financial data and investment advisory tools are offered online.
1984Chicago, Illinois, United StatesUSD 91 MUSD 351.25 K6
Contact databases and sales intelligence are supplied to businesses.
2000Vancouver, Washington, United StatesUSD 32 MUSD 1.25 B3,510
Cloud-based satellite imagery data and analytics solutions are provided.
2010San Francisco, California, United StatesUSD 601.59 MUSD 307.73 M1,749
Online data source platform for information, analytics, and solutions for governments and financial markets
1959London, England, United KingdomUSD 1.41 B––
Experian is recognized as a leader in credit reporting and financial services.
1980Ireland–USD 8.34 B23,300
Provider of credit scoring data for consumers and businesses
1968Chicago, Illinois, United States–USD 4.58 B13,400
Lead management platform with analytics and engagement tools is provided.
2015San Francisco, California, United StatesUSD 250.42 M–928
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Platform for users to share business software reviews
2012Chicago, Illinois, United StatesUSD 257.6 M–1,688
AI-powered market intelligence and search platform is operated.
2011New York, New York, United StatesUSD 1.74 BUSD 6.84 M3,461
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pharmetrics

Premium access

Complete news archive for PharMetrics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PharMetrics

PharMetrics was founded in 1998 and raised its 1st funding round 3 years after it was founded.

PharMetrics is headquartered in Watertown, United States.

PharMetrics is a funded company, having raised a total of $26M across 3 funding rounds to date. The company's 1st funding round was a Series B of $11M, raised on May 2001.

PharMetrics develops healthcare market insight solutions for the pharmaceutical, biotech, medical device, and managed care sectors of the healthcare market. The companys products include Market Profiler that provides a view of a therapeutic market, including market potential, patient demographics showing differences between treated and untreated populations, market segmentation, and an understanding of physician treatment behaviors. It also provides Treatment Profiler, which provides a longitudinal view of actual treatment patterns and allows marketers to understand how and where a particular product fits into the continuum of patient care; and Brand Profiler that provides a brand-specific view of the market, including detailed analysis of the sourceslosses of brand business for a competitive set of brands, and a detailed understanding of where a brand is winning and losing. In addition, the company offers custom analytics and database agreements. The company was founded in 1998 and is headquartered in Watertown, Massachusetts. As of July 1, 2005, PharMetrics, Inc. operates as a subsidiary of IMS Health Holdings, Inc.

PharMetrics's top competitors include Definitive Healthcare, ESO and BioCentury.

PharMetrics has 5 investors. Key investors include IQVIA, IMS Health, 3i Group, North Bridge Venture Partners, and Mediphase Venture Partners.

Yes. PharMetrics was acquired by IMS Health in June 2005.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available